Nisagon Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Betamethasone-17-valerate 0.1%, neomycin sulphate 0.5%

Indications/Uses

Relief of inflammatory of corticosteroid-responsive dermatoses when complicated w/ secondary infections due to neomycin sensitive-organisms.

Dosage/Direction for Use

Apply on the affected areas 2-3 times daily.

Contraindications

Hypersensitivity. Rosacea, acne vulgaris & perioral dermatitis; primary viral skin infection (eg, herpes simplex), extensive use, pregnancy, elderly, patients w/ renal impairment; primary skin lesions due to fungi, bacteria or yeast; dermatoses in childn <1 yr; otitis externa w/ tympanic membrane perforation.

Special Precautions

For external use only, not for eyes. Irritation or sensitization (discontinue). Avoid extensive or prolonged use especially in infants & childn. Duration of treatment in adolescent & face areas max for 5 days, avoid occlusive dressing. Pregnancy & lactation.

Adverse Reactions

Burn sensation, itching, irritation, dry skin, folliculitis, hypertrichosis, allergic-like eruption, skin maceration, secondary infections, skin atrophy, striae, miliaria. Ototoxicity, nephrotoxicity (long-term therapy, large dose).

View ADR Monitoring Form

MIMS Class

Topical Anti-Infectives with Corticosteroids

ATC Classification

D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Nisagon cream

Packing/Price

5 g x 1's (Rp11,583/boks)

Nisagon

betamethasone + neomycin

Manufacturer:

Ifars